Z-2209-2023 Class II Ongoing

Recalled by Cytocell Ltd. — Cambridge, N/A

FDA device recall Z-2209-2023 was initiated by Cytocell Ltd. on May 24, 2023 and is designated Class II. Reason for recall: DNAs used during the manufacture of two affected models were accidentally inverted during manufacturing. The recall status is ongoing. Affected quantity: 60 units.

Recall details

Product Type
Devices
Report Date
Jul 26, 2023
Initiation Date
May 24, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
60 units

Product description

RET Proximal Probe. Used in Fluorescence in situ hybridization (FISH), a laboratory technique for detecting and locating a specific DNA sequence on a chromosome.

Reason for recall

DNAs used during the manufacture of two affected models were accidentally inverted during manufacturing.

Distribution pattern

US Nationwide distribution in the states of CA, FL, OH, & SC.

Code information

Catalog No. LPS508-A; UDI-DI: 05055844900509; Lot No. 076763, 077253, 080125, 080763, 082128, 083041, 083246, 083555.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2209-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2209-2023. Report a data issue: hello@regdatalab.com.